How many investments has Frazier Healthcare Partners made?

Frazier Healthcare Partners has 97 tracked investments, 23 of which have exited, including 7 dated in the last 24 months.

What stage does Frazier Healthcare Partners invest at?

Frazier Healthcare Partners invests at the Growth stage.

What is Frazier Healthcare Partners's typical check size?

Frazier Healthcare Partners typically writes checks of $50M – $400M.

What sectors does Frazier Healthcare Partners focus on?

Frazier Healthcare Partners focuses on Biotech, Digital Health, FemTech, Healthtech, Medical Devices, Wellness & Fitness.

Where is Frazier Healthcare Partners located?

Frazier Healthcare Partners is headquartered in Seattle, US.

Who does Frazier Healthcare Partners co-invest with?

Frazier Healthcare Partners most often shares deals with New Enterprise Associates (NEA), Frazier Life Sciences, Kaiser Permanente Ventures, among 68 tracked co-investors.

Frazier Healthcare Partners

Private equityoperating company · company profile

Seattle · Growth · 51 people tracked

Also known as Frazier Management, L.L.C.

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Frazier Healthcare Partners

3,076 people in our graph share verified history with the Frazier Healthcare Partners team — schools, employers, funds. One of them is your warm intro.

Laura Buhlerunlockedknows Daniel Estes · together at McKinsey & Company (overlapped)

knows the team · via Harvard Business School

×2knows the team · via Stanford University

×3knows the team · via Morgan Stanley Investment Management

knows the team · via McKinsey & Company

knows the team · via University of Michigan

✨ Fox Verdict

Investment thesis

Frazier Healthcare Partners applies a multi-decade, healthcare-specialized investment approach through its Growth Buyout strategy, partnering with profitable and growing companies across the healthcare sector. The firm pairs high-conviction investment themes with proven operating executives, sourced through its Executive in Residence program and extensive healthcare network. Beyond capital, Frazier provides in-house functional resources to help portfolio companies build human capital, strengthen operational infrastructure, and navigate rapid growth, often supporting buy-and-build strategies. The Buyout group has scaled significantly since 1995 and raised over $11 billion of capital for private funds and co-investment opportunities from institutional limited partners globally.

Invests inBiotech Digital Health FemTech Healthtech Medical Devices Wellness & Fitness Canada Europe Seattle United States

Source: firm website, verified Sep 15, 2026.

Stage

Growth

Check

$50M – $400M

Seattle, Washington, US

Instruments

Equity

Founded

1991

Last 12 months

3 investments

AUM

$7.7B

Tracked investments

IPOs

Acquisitions

Team · 51 people

from the firm's website & curated & public directories

Caitlin· Center of Excellence Partner, Human Capital, Growth Buyout· Westport, CT

Joined Frazier in April 2023 as a talent leader with a track record of scaling organizations. Previously on the management team at Bridgewater Associates for nearly two decades as it grew to 1500 people and $150 billion AUM.

Ken· Center of Excellence Partner, Data & Artificial Intelligence, Growth Buyout

Joined Frazier in August 2021 with nearly 20 years in life sciences information services. Previously SVP and GM of Data, Analytics, and Insights at Clarivate and held various leadership roles at Decision Resources Group.

Ben Magnano· Managing Partner· Seattle, Washington, United Statesin

b•••@frazierhealthcare.comreveal

Brian Morfitt· General Partner· Seattle, Washington, United Statesin

b•••@frazierhealthcare.comreveal

Nader Naini· Managing Partner

n•••@frazierhealthcare.comreveal

Nathan Every· MD· Greater Seattle Areain

n•••@frazierhealthcare.comreveal

Steve R. Bailey· CFO, COO and Partner· Greater Seattle Areain

s•••@frazierhealthcare.comreveal

Brent Fierro· General Partner· San Franciscoin

Brent Fierro is a growth equity investor at FTV Capital focused on financial technology and services, where he has worked for over 12 years since joining in 2013. He previously was an investment banking analyst in the financial institutions group at Houlihan Lokey and began his career at the New York Stock Exchange in strategy and data analytics.

b•••@ftvcapital.comreveal

Kevin Tierney· Managing Partner· Greater Philadelphiain

k•••@edisonpartners.comreveal

Shalom Nahum· General Partner· Israelin

Shalom Nahum joined Gemini in 2007 as Senior Controller and became CFO in 2014, focusing on fund management, valuation, and performance analysis. He previously worked as Controller at IBC and Senior Accountant at KPMG, and holds a BA in Business Administration and an MBA in Finance.

s•••@gemini.co.ilreveal

Daniel Estes· General Partner· San Diegoin 𝕏

Dan Estes is a General Partner at Frazier Life Sciences, which he joined in 2011, where he invests in development-stage and commercial-stage pharmaceutical companies. He has co-founded and helped launch several portfolio companies and previously worked as a management consultant in McKinsey & Company's healthcare practice, advising pharmaceutical and biotech firms on R&D and business development strategy. He holds a Ph.D. in Biomedical Engineering from the University of Michigan and a B.S. in Electrical Engineering from Stanford University.

d•••@frazierls.comreveal

Gordon Empey· Partner· Seattlein

Gordon Empey is Chief Operating Officer, General Counsel, and a Partner at Frazier Life Sciences, which he joined in 2017, overseeing the firm's legal, operations, investor relations, compliance, HR, IT, and administrative functions. He has more than 25 years of experience advising venture capital investors and life sciences companies, previously serving as a partner at Cooley LLP and as EVP and General Counsel at Radiant Research, and earlier as General Counsel of the Frazier-sponsored SPAC that merged to form NewAmsterdam Pharma. He holds a J.D. from UC Berkeley (Boalt Hall) and a B.A. in History from Colgate University, and earlier served as an officer in the U.S. Navy Judge Advocate General Corps.

g•••@frazierls.comreveal

James W. Brush· General Partner· Palo Altoin

Jamie is a General Partner and Portfolio Manager at Frazier Life Sciences, which he joined in 2016, investing in private and public biotechnology companies. He co-leads Frazier's public equity investment strategy and serves as co-Portfolio Manager of the Frazier Life Sciences Public Fund alongside Albert Cha. Before Frazier, he was a management consultant at the Boston Consulting Group within its Healthcare Practice, and he holds an M.D. from the University of Southern California and a B.A. from Middlebury College.

j•••@frazierls.comreveal

Patrick Heron· Managing Partner· Palo Altoin

Patrick Heron co-leads Frazier's Life Sciences team and is a Managing Partner and co-founder of that team, having joined the firm in 1999 and opened its Palo Alto office in 2003. He invests across therapeutics, from early-stage drug development to commercial-stage pharmaceutical companies. Before Frazier, he helped build McKinsey & Company's West Coast biotechnology consulting practice, and he holds an M.B.A. from Harvard Business School and a B.A. from the University of North Carolina at Chapel Hill.

p•••@frazierls.comreveal

Ilene Cheung· Seattle, Washington, United Statesin

Jeremy Janson· New York, New York, United Statesin

Jim Brady

Michael Machak· Center of Excellence Partner, Mergers & Acquisitions· New Yorkin

Joined Frazier in August 2022 with over 20 years of M&A and management consulting experience, leading integration and value maximization efforts across the portfolio. Previously a Senior Director at A&M's PE practice, at EY-Parthenon, and six years at McKinsey.

Nicole· Center of Excellence Principal, Commercial Strategy and Marketing· New York

Joined Frazier in April 2023 and promoted to Center of Excellence Principal in January 2025, supporting portfolio company commercial strategy, marketing, and sales. Previously VP of Commercial Strategy at Cerberus Capital Management and Director of Strategy at Publicis Groupe.

Christina Reszka· Partner· Greater Seattle Areain

c•••@frazierhealthcare.comreveal

Kent Berkley· Partner· Greater Seattle Areain

k•••@frazierhealthcare.comreveal

Philip Zaorski· General Partner· New York, New York, United Statesin

p•••@frazierhealthcare.comreveal

Ryan Lucero· Partner· Greater Seattle Areain

r•••@frazierhealthcare.comreveal

Shyamal Swami· Principal· Seattle, Washington, United Statesin

s•••@frazierhealthcare.comreveal

Laura Gleason Moore· Principal· Beverly Hills, California, United Statesin

Laura Gleason Moore is Director of Operations at Berggruen Holdings, where she oversees operational strategy, processes, and performance across multiple sectors and regions in coordination with the CFO and other senior leaders. She joined the company more than seven years ago as Administrative Director before advancing to her current role, working on structuring, financing, compliance, investment projects, business development, and communications. Her earlier career included real estate positions at Colony Capital, GPI Companies, and Joseph Cohen Real Estate, and she studied English and Business at USC.

Maria Fardis· Venture Partner· Palo Altoin

Maria Fardis joined Frazier Life Sciences as a Venture Partner in 2021 and has more than 20 years of scientific and management experience across public and private companies. She currently serves as CEO of Lassen Therapeutics and previously held leadership roles including President and CEO of Iovance Biotherapeutics, COO of Acerta Pharma, and senior positions at Pharmacyclics and Gilead Sciences. She holds a Ph.D. in Organic Chemistry from UC Berkeley, a B.S. in chemistry from the University of Illinois, Urbana-Champaign, and an M.B.A. from Golden Gate University.

Andrew Wu· Seattle, Washington, United Statesin

Daniel Ewnetu· Seattle, Washington, United Statesin

David· Executive in Residence, Growth Buyout

Re-joined Frazier as an Executive in Residence focused on home health, hospice and related areas. Previously co-founder and CFO of Abode Healthcare, a Frazier portfolio company acquired by BrightSpring Healthcare, and earlier worked at Trident Capital, Spectrum Equity Investors, and Alex. Brown.

Jennifer Zhuang· Seattle, Washington, United Statesin

Maria· Executive in Residence

Joined Frazier in May 2024 focused on women's health and wellness. Former CEO of Thinx, which she scaled to a $130M+ brand and sold to Kimberly Clark, with prior executive roles at eBay, Fab.com, Thomson Reuters, Dow Jones, Yahoo, and Disney.

Matt Hinshaw· Seattle, Washington, United Statesin

Mike Gawlik· New York, New York, United Statesin

Milton Boyer· Executive in Residence· Atlanta Metropolitan Areain

Joined Frazier in June 2026 focused on clinical services investments. Former CEO of Kindeva Drug Delivery and SCA Pharmaceuticals, with a career spanning pharmaceutical contract development and manufacturing (CDMOs).

Reema· Center of Excellence, Technology and Innovation· Toronto, Ontario, Canada

Joined Frazier in May 2021 with over 16 years in healthcare, focused on technology implementations and M&A integrations. Previously Director of IT Operations at SOCTelemed and spent six years at DrFirst.

Steve Krupa· Executive in Residence

Joined Frazier in June 2026 focused on healthcare information technology. Former CEO of HealthEdge, which he grew to $400M+ revenue through two exits, and previously a healthcare venture capital partner at the Psilos Group.

Volodymyr Gulidov· New York, New York, United Statesin

Clarissa Berman· Principal· Seattle, Washington, United Statesin

Clarissa Berman is a Principal at Frazier Healthcare Partners. Her experience spans private and public equities, business and corporate strategy, and start-ups.

c•••@frazierhealthcare.comreveal

Angie You· Senior Advisor· South San Francisco, California, United Statesin

Angie You is co-founder and CEO of Architect Therapeutics. She also serves as co-founder and board member of non-profit organization ElevAAte Biotech, bringing expertise in company building, business development, licensing, M&A, corporate strategy, and commercial marketing.

April Petersen· Senior Accountant· Greater Seattle Areain

Ateeq Farooqui· Vice President, Technology & Innovation· Ashburn, Virginia, United Statesin

Investment consultant supporting investment banks and management firms across traditional and alternative investments including hedge funds, fund of funds, private equity, VC, and wealth management.

Chris Peetz· Entrepreneur-in-Residence· San Francisco Bay Areain

Chris Peetz is Chief Executive Officer and co-founder of Mirum Pharmaceuticals. He brings experience in finance, corporate development, marketing, and executive leadership within the biopharmaceutical industry.

Don Frail· Senior Advisor· United Statesin

Don Frail is founder and CEO of Alceptor Therapeutics and has held senior leadership positions in drug discovery and clinical development across multiple therapeutic areas. He has built and managed R&D organizations ranging from 25 to 200 employees, with experience advancing more than 25 compounds into clinical development across modalities including small molecules, monoclonal antibodies, gene therapy, and CRISPR. Since 2015, Frail has participated in more than 25 business development transactions, including acquisitions, licensing agreements, and partnership structures.

Gordon McMurray· Entrepreneur In Residence· United Kingdomin

Gordon McMurray joined Frazier Life Sciences as an Entrepreneur-in-Residence in March 2020 and has over 18 years of experience in drug discovery and development. He previously co-founded and served as Chief Scientific Officer at Outpost Medicine, and earlier held senior R&D roles at Pfizer across neuroscience, pain, sensory disorders, and urology, as well as a lectureship and lab head position in pharmacology at Oxford University. He earned a B.Sc. and Ph.D. from Queen's University Belfast.

Ian W. Mills· Entrepreneur in Residence· United Kingdomin

Ian W. Mills is an Entrepreneur-in-Residence at Frazier Life Sciences, having joined in March 2020, with a background as a pharmaceutical development executive. He previously served as Chief Medical Officer at Outpost Medicine and Head of Clinical Development at Mitsubishi Tanabe Pharma Europe, and spent over 15 years at Pfizer in clinical and development leadership roles. He holds an MA in Natural Sciences from Cambridge University and a medical degree and medical doctorate from Oxford University.

Maria Molland· Executive in Residence· San Francisco Bay Areain

Investor, operator, and board director with 25+ years scaling consumer and healthcare businesses; former CEO and board member of Thinx, with prior leadership roles at eBay, Yahoo, Thomson Reuters, Dow Jones, Fab.com, and Disney.

Roger Ulrich· Senior Advisor· Greater Seattle Areain

Roger Ulrich is a biotech executive and entrepreneur with experience in drug discovery and development, regulatory affairs, company formation, and financing. He serves as a board member at Telios Pharma, Inc.

Tyson Smith· Vice President· Greater Sydney Areain

Angel Martin· Senior Associate· San Diegoin

Angel Martin is a Vice President at Frazier Life Sciences, which she joined in 2021 to evaluate investment opportunities in the life sciences sector. She previously worked as an Investment Fellow with Vertex Ventures Healthcare and held roles as Director of Research and Venture Grants at Emerson Collective, Health and Research Director of the Friedreich Ataxia Research Alliance. She holds a Ph.D. in Pharmacology and Cancer Biology from Duke University and a B.A. from the University of Michigan, Ann Arbor.

a•••@frazierls.comreveal

Joe Cabral· Senior Associate· Bostonin

Joe Cabral is a Partner at Frazier Life Sciences, which he joined in 2021, working on the firm's private investment and company creation strategies. Before that, he worked in venture creation at Flagship Pioneering and was a founding team member at Generate:Biomedicines in protein engineering and strategy roles, and earlier was an early employee at Moderna focused on molecular biology and informatics. He holds an MBA from the University of Michigan's Ross School of Business, and an M.S. in Genomics and a B.S. in Biology from the University of Connecticut.

j•••@frazierls.comreveal

John Payton· Senior Manager, Portfolio Valuation & Analytics· Seattle, Washingtonin

Founder mafia

The Frazier Healthcare Partners mafia →

8 people who came through Frazier Healthcare Partners went on to found or lead other companies.

Maria FardisVenture PartnerFounded Iovance +2 Brian FarmerEntrepreneur in ResidenceFounded Inipharm Gordon McMurrayEntrepreneur In ResidenceFounded Outpost Medicine Chris PeetzEntrepreneur-in-ResidenceFounded Mirum Pharmaceuticals Angie YouSenior AdvisorFounded Architect Therapeutics Mark GilreathOperating PartnerFounded United Digestive Milton BoyerExecutive in ResidenceFounded SCA Pharma Krishna PoluDirector Board of DirectorsFounded Commit Biologics

What they invest in

from 64 of 97 portfolio companies

Healthtech ×46Biotech ×28Digital Health ×22Medical Devices ×22SaaS ×9Advanced Manufacturing ×8AI & Machine Learning ×6Logistics & Supply Chain ×6

HQs:United States×43Canada×1

Investments · 97 tracked

founders shown can be your intro path

By year:2026 · 1 2025 · 5 2024 · 3 2023 · 1 2022 · 3 2021 · 4 2020 · 5 2019 · 2 2018 · 1 2016 · 2 2014 · 128 dated

BrightSpring Louisville, KYbrightspringhealth.com in 𝕏NASDAQ: BTSGSep 2024

BrightSpring Health Services operates complementary home and community-based health services for complex populations requiring specialized or chronic care, including home health, hospice, senior care, and pharmacy management across all 50 U.S. states.

Digital HealthHealthtechWellness & Fitness

Jennifer Yowler(President, PharMerica)Mike McMaude(President, Home Health and Hospice Services)Jim Mattingly(Executive Vice President and Chief Financial Officer)inLisa Nalley(Chief of Staff and Senior Vice President, Human Resources)inJon Rousseau(Chairman, President, and Chief Executive Officer)inBob Barnes(President, Community Living)

Co-investorsEpsilon Health Investors

Maze Therapeuticsmazetx.com in 𝕏NASDAQ: MAZEDec 2024 · $120M

Maze Therapeutics develops precision medicines for common diseases with high unmet need, using its Compass platform based on human genetics and variant functionalization.

AI & Machine LearningBiotechSouth San Francisco, US

Charles Homcy(Director)Jason Coloma(Chief Executive Officer)in

Co-investorsAndreessen Horowitz ARCH Venture Partners Foresite Capital Frazier Life Sciences GV (Google Ventures)Janus Henderson Investors +3 more

Mirum Pharmaceuticalsmirumpharma.com in 𝕏NASDAQ: MIRMSeries A · Nov 2018 · $120M

Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases.

BiotechHealthtechSan Diego, US

Chris Peetz(Co-founder & Chief Executive Officer)in Eric Bjerkholt(Executive Officer)in Peter Radovich(Executive Officer)in

Board Patrick Heron(Director)inMichael Grey(Director)Timothy Walbert(Director)

Co-investorsChiesi Ventures Frazier Life Sciences New Enterprise Associates (NEA)Pappas Capital RiverVest Venture Partners Deerfield Management Company +2 more

Passage Biopassagebio.com in 𝕏NASDAQ: PASGSeries A · Aug 2019 · $120M

Passage Bio is a biotechnology company developing treatments for central nervous system (CNS) diseases, with a focus on neurodegenerative conditions.

BiotechHealthtechPhiladelphia, US

William Chou(Chief Executive Officer)Tadataka Yamada(Executive Officer, Director, Promoter)Stephen Squinto(Executive Officer, Director)in

Board Patrick Heron(Director)in Carl Gordon(Director)inThomas Street Address 1 Woiwode(Director)

Co-investorsFrazier Life Sciences Access Biotechnology New Leaf Venture Partners OrbiMed Sphera Funds Management Versant Ventures +1 more

Vatica Healthvaticahealth.com in 𝕏✓ verified

Vatica Health develops software solutions for primary care physicians, health plans, and providers to improve the Medicare Annual Wellness Visit and risk adjustment processes.

Digital HealthEnterprise SoftwareHealthtechMedical DevicesSaaS

Steve Zuckerman(Co-founder)inAverel Snyder(Co-founder)in Keith Anderson(Chief Executive Officer)in

Co-investorsGreat Hill Partners Optum Ventures

Accuityhealthcareaccuityhealthcare.com in

Accuity provides software solutions to hospitals for managing clinical documentation standards, regulatory compliance, and healthcare revenue cycle optimization.

AI & Machine LearningDigital HealthHealthtechSaaS

Adarepharmasolutionsadarepharmasolutions.com in 𝕏

Adare Pharma Solutions is a CDMO (contract development and manufacturing organization) and pharma services provider serving the biopharma industry with manufacturing, research and development, and patient support capabilities.

Advanced ManufacturingBiotechHealthtechMedical Devices

Tom Sellig(Chief Executive Officer)in Jason Arcediano(Chief Commercial Officer)inDavid Durkin(Chief Financial Officer)inRussell Lindenfeldar(Chief Legal Officer)in Luisa Rodriguez(Chief Human Resources Officer)in Naresh Sethi(Chief Information Officer)in

Agilitihealthagilitihealth.com in

Agiliti provides medical equipment management, rental, and clinical engineering services to hospitals and health systems, covering compliance, supply chain cost control, and biomed device support.

HealthtechLogistics & Supply ChainMedical Devices

Tom Leonard(Chief Executive Officer)Matthew McCabe(Executive Vice President and Chief Financial Officer)Bettyann Bird(Executive Vice President and Chief Strategy Officer)Bob Creviston(Executive Vice President and Chief Human Resources Officer)Lee Neumann(Executive Vice President and General Counsel)Matt Neale(Senior Vice President of IT and Chief Information Officer)

AirLifemyairlife.com in

AirLife manufactures airway management medical devices, including endotracheal tubes and pharyngeal airways, used to maintain or restore safe airways for oxygenation and ventilation.

Advanced ManufacturingHealthtechMedical DevicesGrand Rapids, US

Alestaalestatherapeutics.com inSeries A · Jan 2025 · $67M

Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology.

BiotechHealthtech

Ilan Ganot(CEO)inBenit Maru(CMO)Matthias Van Woensel(CSO)in

Co-investorsDroia Ventures Frazier Life Sciences Novartis Venture Fund MPM BioImpact RTW Investments L.P.Thuja Capital

Alpha-9 Oncologya9oncology.com inSeries B · Dec 2022 · $75M

Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development.

BiotechDigital HealthMedical DevicesVancouver, CA

François Bénard(MD)Kuo-Shyan Lin(PhD)David Perrin(PhD)

Co-investorsAndreessen Horowitz Ascenta Capital Delos Capital General Catalyst Lightspeed Venture Partners Longitude Capital +9 more

Alteon Healthalteonhealth.com in 𝕏acquired by US Acute Care Solutions

Alteon Health is a physician-owned and physician-led acute care medical group that partners with hospitals and health systems to provide hospitalist medicine, post-acute care, and clinical staffing.

Digital HealthHealthtech

Co-investorsNew Mountain Capital

Altruixaltruix.com in 𝕏

Altruix operates local, independent pharmacies in the mid-Atlantic region, offering person-centered pharmacy services that specialize in behavioral health, intellectual and developmental disabilities, and substance use disorder.

Digital HealthHealthtechMental Health

Randy Hyun(Chief Executive Officer)in

Amunixamunix.comSeries A · Mar 2020 · $73M

Co-investorsLongitude Capital

AppianRxappianrx.com in

Specialty pharmacy serving patients with chronic, complex conditions; based in Houston, TX.

Aspen Neuroscienceaspenneuroscience.com in 𝕏Apr 2020 · $70M

Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.

BiotechDeep TechDigital HealthMedical Devices

Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)in Damien McDevitt(President and Chief Executive Officer)in

Co-investorsARCH Venture Partners Lifeforce Capital OrbiMed Domain Associates EDB Investments Section 32 +4 more

Beloitbeloitdailynews.com 𝕏

Beloit Daily News is a local news publication covering Beloit, Wisconsin and surrounding Rock and Walworth county communities, reporting on local events, crime, education, business, sports, and real estate.

Media & EntertainmentBeloit, US

Bluejay Therapeutics inSeries C · May 2024 · $180Macquired by Mirum Pharmaceuticals · Dec 2025 · $620M

Healthcare company acquired by Mirum Pharmaceuticals, a former RiverVest portfolio company.

San Mateo, US

Keting Chu(Executive Officer, Director)inDajun Yang(Director)Nancy Hong(Director)inAlon Lazarus(Director)William J. Rutter(Director)Ting Jia(Director)

Co-investorsFrazier Life Sciences RA Capital RiverVest Venture Partners HBM Healthcare Investments Novo Holdings T. Rowe Price +1 more

Bravo Healthbravohealth.com inacquired by HealthSpring

Medicare Advantage and Part D prescription drug plans; based in Baltimore, MD.

Co-investorsNew Enterprise Associates (NEA)

Caravel Biocaravel.bio in

Caravel engineers proteins into scalable industrial "protein machines" for applications including critical minerals recovery, carbon capture, and industrial processes.

BiotechClimate TechDeep Tech

Trevor Nicks(Founder & CEO)in Emily Bowman(CSO)in Michał Jastrzębski(CTO)inAgneya Bhushan(CINO)in

Co-investors2048 Ventures Portland Seed Fund The Venture Collective

Caravelautismcaravelautism.com in 𝕏

Caravel Autism Health provides evaluation, diagnosis, and data-driven therapy programs for children with autism, supported by their proprietary PathTap™ outcomes platform for clinical progress tracking and analysis.

Digital HealthHealthtechMedical DevicesMental Health

CHG Healthcarechghealthcare.com

Prior Firm Investment shown for illustrative purposes; not a Whistler fund investment.

Co-investorsLeonard Green New Enterprise Associates (NEA)Whistler Capital Partners

Cirius Therapeuticsciriustx.com

Cirius Therapeutics is a clinical-stage pharmaceutical company developing therapies for patients with chronic metabolic diseases driven by insulin resistance, including Type 2 Diabetes and obesity.

BiotechDigital HealthGrand Rapids, US

Jerry Callahan(Executive Officer)Brian Farmer(Executive Officer)inRobert Baltera(Executive Officer, Director)Howard Dittrich(Executive Officer)

BoardMichael Jandernoa(Director)Mark Olesnavage(Executive Officer)

Co-investorsNovo Holdings

Comprehensive Pharmacy Servicescpspharm.com

CPS Solutions provides pharmacy management services to hospitals and health systems, including specialty pharmacy, 24/7 telepharmacy support (remote order entry and verification, transitions of care), 340B compliance, rehabilitation, and materials management.

Digital HealthEnterprise SoftwareHealthtech

Co-investorsAscension Ventures

Correct Care Solutionscorrectcaresolutions.com

Provides healthcare services to underserved populations in state hospitals and detention settings; based in Nashville, TN.

Csafeglobalcsafeglobal.com in

CSafe develops temperature-controlled shipping solutions for the pharmaceutical and life sciences cold chain, including active and passive air cargo containers, parcel shippers, and cryogenic dewars for cell and gene therapies.

Advanced ManufacturingBiotechHealthtechIoTLogistics & Supply ChainMonroe, US

Patrick Schafer(Chief Executive Officer)Scott Lathrop(Chief Financial Officer)in Niall Prendiville(Chief (Engineering/Operations))inMicki Turner(Chief Human Resources Officer)Sofia Pokatilova(Chief Legal / General Counsel)in

Co-investorsBCI

Effective School Solutionseffectiveschoolsolutions.com in 𝕏

Effective School Solutions provides guidance and resources to school districts on securing and sustaining funding for mental and behavioral health services.

Digital HealthEdTechGovTechHealthtechMental Health

Dr. Norris(Chief Executive Officer)inLisa Ciappi(Chief Clinical Officer)inJerry(Chief Clinical Officer)

Co-investorsHavencrest Capital Management

Elevatepfselevatepfs.com in 𝕏

Elevate Patient Financial Solutions provides revenue cycle management services for healthcare providers, including eligibility, complex claims, third party liability, workers' compensation, extended business office, and patient care scheduling.

FintechHealthtechSaaS

Michael Shea(Chairman & Chief Executive Officer)Frank Stellato(Chief Financial Officer)Nicole Guido(Chief Growth Officer)Emily Fisher(Division President & COO, Patient Outreach)Justin Myers(Division President & COO, Complex Claims)Jack Tindal(Chief People Officer)

Eptameptam.com inMay 2014

EPTAM provides precision machining, plastics, and molding manufacturing services for regulated industries including medical and aerospace sectors.

Advanced ManufacturingBiotechHardwareHealthtechMedical DevicesBoston, US

Bill Flaherty(President & Chief Commercial Officer)inJudson Samuels(Executive Officer)Mark Jrolf(Executive Officer)

Golden State Medical Supplygsms.us inacquired by Court Square Capital Partners

A pharmaceutical company that markets a portfolio of drug products across various dosage forms, with labeling and packaging following FDA requirements.

Advanced ManufacturingBiotechHealthtechLogistics & Supply Chain

Rick Ryan(Executive Director and Founder, WSI)Benjamin Hall(Chief Executive Officer)in David Arnold(President/Chief Operating Officer)in Sonia De La Rosa(Chief Commercial Officer, Corporate Development and Strategy)in

Co-investorsFulcrum Equity Partners New Enterprise Associates (NEA)

HilleVaxhillevax.com inApr 2022 · $140Macquired by XOMA Royalty

XOMA Royalty is a biotech royalty aggregator that acquires the economic rights to future milestone and royalty payments tied to partnered pre-commercial clinical candidates, providing sellers with non-dilutive, non-recourse funding.

BiotechFintech

Co-investorsCatalys Pacific Frazier Life Sciences Lightspeed Venture Partners RA Capital Samsara BioCapital

HOPCohopco.com

HOPCo brings together executives from musculoskeletal medicine, hospital and health system management, insurance, and healthcare IT to manage and coordinate care and alternative payment models.

Digital HealthHealthtechMedical DevicesPhoenix, US

David J. Jacofsky(Founder, Chairman and Chief Executive Officer)in Wael Barsoum(President & Chief Transformation Officer)inLeAnne Stewart(Chief Financial Officer)Jason Scalise(Chief Value Officer)in Peter J. Slate(Chief Corporate Development Officer)in Chris Martinez(Global Chief Information Officer)in

Co-investorsPrinceton

Hummingbirdhummingbird-tech.comMay 2021

OLG Machinery, founded in 2008, trades new and certified used industrial spare parts and machinery, serving U.S. companies operating across North and South America with a focus on Mexico.

Advanced ManufacturingB2B MarketplacesLogistics & Supply Chain

Co-investorsOxford Investment Opportunity Network (OION)Ally Bridge Group Altium Capital Amgen Ventures Droia Ventures Novo Holdings +2 more

Hummingbird Biosciencehummingbirdbioscience.com in 𝕏May 2021

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.

AI & Machine LearningBiotechDeep TechHealthtech

Piers Ingram(Chief Executive Officer, Co-Founder, Executive Director)in Jerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)Dipti Thakkar(Chief Operating Officer)in

Co-investorsAltium Capital ClavystBio Decheng Capital Droia Ventures Frazier Life Sciences Kiwoom Investment +5 more

Imagoimagobio.com in 𝕏Nov 2020 · $80M

A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.

BiotechHealthtech

Co-investorsHighlight Capital Amgen Ventures BlackRock Blackstone Life Sciences Clarus Ventures Greenspring Associates +4 more

Inipharminipharm.com in

Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.

BiotechHealthtechMedical Devices

Brian Farmer(Co-Founder, Chief Executive Officer)inHeather Hsu, PhD(Co-Founder, Chief Scientific Officer)Michael Gallatin, PhD(Co-Founder, SAB Chair)Chuhan Chung(Chief Medical Officer)in

Co-investors5AM Ventures Frazier Life Sciences Wu Capital

Iolyxiolyx.com inSeries B · Dec 2025 · $15M

Iolyx is a pharmaceutical company focused on developing treatments for ocular conditions.

BiotechMedical Devices

Elizabeth Jeffords(CEO & President)inErin Newman(Chief Development Officer)in Shannon Dahl(Chief Scientific Officer)in Bryan Boyle(Chief Legal & Administrative Officer)in

Co-investorsFrazier Life Sciences

Knipperknipper.com in

Knipper provides multi-modal pharmaceutical fulfillment and dispensing services, including patient access solutions, pharmacy fulfillment, samples management, and third-party logistics for pharma companies.

Digital HealthHealthtechLogistics & Supply Chain

Co-investorsFrazier Life Sciences

Konovokonovo.com in

Konovo operates an AI-enabled platform and services connecting healthcare market researchers and data scientists with vetted respondents such as physicians, patients, and payers for primary research.

AI & Machine LearningHealthtechSaaS

Lassen Therapeuticslassentherapeutics.com inJun 2020 · $31M

Lassen Therapeutics is a biotechnology company developing therapeutics targeting IL-11, with a pipeline focused on immune and fibrotic diseases.

Biotech

David King(Co-Founder & CSO)in Maria Fardis(CEO)in Cadmus C. Rich(Chief Medical Officer)in Elaine Stracker(General Counsel)in

Co-investorsAlta Partners Catalio Capital Management, LP DC Investment Partners Longitude Capital Longwood Fund Biotechnology Value Fund +2 more

Leitersleiters.com in

Leiters Health is an FDA-registered 503B outsourcing facility that produces sterile compounded preparations for hospitals, surgery centers, and ophthalmic use.

BiotechHealthtechMedical DevicesDenver, US

Co-investorsCorewell Health Ventures Escalate Capital Partners H.I.G. Capital H.I.G. HealthBridge Partners Kaiser Permanente Ventures Rex Health Ventures +2 more

LUX Infusionluxinfusion.com in 𝕏

LUX Infusion operates infusion centers and pharmacies that administer specialty intravenous and subcutaneous medications for patients with autoimmune disorders, neurological conditions, immune deficiencies, chronic infections, and other complex conditions.

Digital HealthHealthtechMedical Devices

Matrix Medical Networkmatrixmedicalnetwork.com in

Matrix Medical Network is an independent provider of comprehensive in-home health assessments serving people across the United States.

Digital HealthHealthtechMedical Devices

Marcia Naveh, MD, FACP, CMD(Founder)in

MatrixCarematrixcare.com in 𝕏

MatrixCare provides digital software tools designed for post-acute care settings, including home-based and long-term care facilities, to manage patient intake, medical records, pharmacy, reimbursement, and compliance.

Digital HealthEnterprise SoftwareHealthtechSaaS

Tim Smokoff(General Manager, MatrixCare)in

Co-investorsOMERS Private Equity Inc.

MBX Biosciencesmbxbio.com in 𝕏Series A · Jul 2020 · $35M

MBX Biosciences is a clinical-stage biopharmaceutical company developing peptide therapeutics for endocrine and metabolic diseases.

BiotechHealthtechCarmel, US

Richard DiMarchi(Executive Officer, Director)Peter Kent Hawryluk(Executive Officer, Director)Timothy Knickerbocker(Executive Officer, Director)inSteve Hoerter(Chairman & Chief Executive Officer)inSalomon Azoulay(Chief Medical Officer)inKaren Basbaum(Chief Business Officer)in

Co-investorsFrazier Life Sciences Norwest Venture Partners IU Ventures New Enterprise Associates (NEA)OrbiMed

NetCitadelin 𝕏Acquired

Proofpoint provides cybersecurity and compliance software that protects organizations' people, data, cloud environments, and email from advanced cyber threats.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaS

Ashan Willy(CEO)Sumit Dhawan(Chief Executive Officer)Rémi Thomas(Chief Financial Officer)Kim Sullivan(Chief People Officer)Mayank Choudhary(EVP and GM, Information Protection, Cloud Security & Compliance Products Group)Tom Corn(EVP and GM, Threat Protection Group)

Co-investorsCrane Venture Partners Dag Ventures Elevate Ventures Gamut Glynn Capital Management Granite Hill+12 more

Parataparata.com in 𝕏acquired by BD

Parata develops pharmacy automation solutions that help pharmacies improve efficiency, patient medication adherence, and operational costs.

Enterprise SoftwareHardwareHealthtechRoboticsSaaS

Patheonpatheon.com in 𝕏

Patheon, part of Thermo Fisher Scientific, is a contract development and manufacturing organization (CDMO) that also offers clinical research (CRO) services for biotechnology and pharmaceutical sponsors.

Advanced ManufacturingBiotechHealthtech

Co-investorsAmpersand

PCIpci.com

PCI is a contract development and manufacturing organization (CDMO) that supports pharmaceutical clients from early-stage drug development through commercialization, including sterile drug manufacturing.

Advanced ManufacturingBiotechHealthtech

Pentec Healthpentechealth.com in 𝕏acquired by Norwest Equity Partners

Pentec Health is a national provider of clinical nutrition and specialty care services, integrating pharmacy services with clinical expertise for patients with complex conditions including dialysis, wound care, metabolic disorders, and oncology needs.

Digital HealthHealthtechMedical Devices

Joe Cosgrovein

Co-investorsWellspring

Pentec Health Celebrates 35th Anniversaryin 𝕏acquired by Wellspring Capital Management · Oct 2021

This page is a distribution, marketing, and reseller partner directory for PRWeb, an online press release distribution service.

Marketing TechMedia & EntertainmentSaaS

Co-investorsAdvance Venture Partners Angel Physicians Fund Avestria Ventures Aviv Venture Capital BIGR Ventures Blue Venture Funds+15 more

Pharmiwebpharmiweb.com

PharmiWeb.com was an online career and jobs community for the pharmaceutical industry, connecting professionals with opportunities from entry-level to VP positions.

HealthtechHR Tech

Presspubspresspubs.com

Press Publications operates a local news outlet covering communities in the east metro area of Minnesota, including White Bear Lake, Shoreview, Arden Hills, and Mahtomedi.

Media & Entertainment

Psychpsychcongress.com

Psych Congress runs in-person psychiatry conferences and educational events focused on practical psychopharmacology and clinical treatment strategies.

EdTechHealthtechMental Health

Radionetics Oncologyradioneticsoncology.comSeed · Oct 2021 · $30M

BiotechMenlo Park, US

Brett Ewald(Executive Officer)inUmesh Gangadharmath(Executive Officer)in Istvan Molnar(Executive Officer)inYunfei Zhu(Executive Officer)Ana Kusnetzow(Executive Officer)inScott Struthers(Director)

Co-investorsDCVC (Data Collective)Frazier Life Sciences 5AM Ventures DCVC Bio Westlake Village BioPartners

RevSpringrevspringinc.com in 𝕏

RevSpring provides patient and member engagement solutions for healthcare providers and payers, combining behavioral data, financial insights, and multi-channel (digital and print) communications to guide patients from provider search through final payment.

AI & Machine LearningDigital HealthHealthtech

Brandon Spring(Chief Commercial Officer & Kyruus GM)

Co-investorsBeringea New Enterprise Associates (NEA)

Sidewinder Therapeuticssidewinderbio.com inSeries B · Apr 2026 · $140M

Sidewinder Therapeutics is a biotechnology company focused on oncology drug discovery and development, working on next-generation cancer treatments.

BiotechHealthtechMedical DevicesSan Diego, US

Eric Murphy(Chief Executive Officer, Co-Founder, & Director)in

Co-investorsAstellas Venture Management LLC DCVC (Data Collective)DCVC Bio Frazier Life Sciences Longwood Fund Novartis Venture Fund +2 more

Solis Women’s Health Addison, TXsolismammo.com in

Solis Mammography operates specialized breast imaging centers offering screening and diagnostic mammograms using 3D mammography and SmartCurve compression technology, along with AI-assisted early cancer detection.

FemTechHealthtechMedical Devices

Co-investorsEpsilon Health Investors TowerBrook

Sudo Biosudobio.comSeries A · Sep 2022 · $37M

Sudo Biosciences develops small molecule therapeutics for neurological and immune-mediated inflammatory conditions.

BiotechHealthtechMedical DevicesMenlo Park, US

Jim Bristol(Director)Daniel Estes(Director)in Scott Byrd(Executive Officer, Director)in

Co-investorsFrazier Life Sciences Monograph Capital Partners Sanofi Ventures SV Health Investors Dementia Discovery Fund TPG

Transformmagazinetransformmagazine.net in 𝕏

Transform magazine is a quarterly publication covering brand strategy, rebranding, and brand development across sectors globally.

Marketing TechMedia & Entertainment

Tri-Imagingtriimaging.com in

Tri-Imaging sells, leases, repairs, and sources parts for medical imaging equipment, and operates an apprenticeship program for training professionals in medical imaging services.

HardwareHealthtechMedical DevicesNashville, US

Eric Wright(Founder)in

Tridentcaretridentcare.com in

TridentCare provides clinical services to elderly and post-acute patients through a combination of technology and clinical workforce.

Digital HealthHealthtechLogistics & Supply ChainMedical Devices

David Velez in

Tubulis GmbHtubulis.com in 𝕏Series C · Oct 2025 · $400Macquired by Gilead Sciences

The page is a placeholder shell showing only cookie/consent notices for embedded third-party content (Vimeo, YouTube, reCAPTCHA, social media) and contains no substantive information about the company.

Dominik Schumacher(Founder)in

Co-investorsAndera Partners Ascenta Capital BioMedPartners Frazier Life Sciences Fund+Nextech Invest +1 more

U S Renal Careusrenalcare.com in

U.S.

Digital HealthHealthtechMedical Devices

Co-investorsKaiser Permanente Ventures Leonard Green New Enterprise Associates (NEA)Revelstoke Capital Partners Summit Partners SV Health Investors

United Digestiveuniteddigestive.com inMar 2023acquired by Kohlberg & Company

United Digestive is a provider of gastroenterology and digestive healthcare services, operating through partner physician practices that offer diagnostic and in-office treatment services.

Digital HealthHealthtechAtlanta, US

Evan Wildstein(President)Whitney Hanson(Vice President and Secretary)Mark Gilreath(Chief Executive Officer)inRobert A. Cucuel, Jr.(Director)Neal C. Patel(Director)H. Lynn Massingale(Director)

Uniteddermpartnersuniteddermpartners.com

United Derm Partners provides patient-centered services to dermatology practices across the United States.

Digital HealthHealthtechMedical DevicesSaaSBrentwood, US

Vuru𝕏acquired by Wave Accounting (Wave Financial/Wave HQ) · Aug 2012

Vuru was an online tool that analyzed public companies' financial statements into simplified stock reports and portfolio-tracking for retail investors.

Co-investorsBackbone Angels

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Abode HealthcareAccuityAccuity Delivery SystemsAdareBE BiopharmaBeckersascCallio TherapeuticsCareTriaCPS SolutionsCSafeDSI RenalEIS investmentElevate Patient Financial SolutionsHillstar BioImago BioSciences, Inc.Laboratory Supply CompanyLabscoMedPointeMerganser BiotechNorthfield MedicalOcteta Therapeutics Outpost MedicinePciservicesPriority SolutionsRecida TherapeuticsSanReno TherapeuticsSolis MammographyTailwind Capital Acquires Abode HealthcareTrident USA Health ServicesUnited Derm

Exits · 23

4 IPOs · 19 acquisitions · showing 22

BrightSpring Louisville, KYNASDAQ: BTSGMaze TherapeuticsNASDAQ: MAZEMirum PharmaceuticalsNASDAQ: MIRMPassage BioNASDAQ: PASGAbode Healthcareacq. by Tailwind CapitalAlteon Healthacq. by US Acute Care SolutionsBluejay Therapeuticsacq. by Mirum PharmaceuticalsBravo Healthacq. by HealthSpringGolden State Medical Supplyacq. by Court Square Capital PartnersHilleVaxacq. by XOMA RoyaltyLaboratory Supply Companyacq. by McKessonMedPointeacq. by MedaNorthfield Medicalacq. by AgilitiParataacq. by BDPentec Healthacq. by Norwest Equity PartnersPentec Health Celebrates 35th Anniversaryacq. by Wellspring Capital ManagementPriority Solutionsacq. by Thermo Fisher ScientificSolis Mammographyacq. by Madison Dearborn PartnersTrident USA Health Servicesacq. by Formation CapitalTubulis GmbHacq. by Gilead SciencesUnited Digestiveacq. by Kohlberg & CompanyVuruacq. by Wave Accounting (Wave Financial/Wave HQ)

Portfolio news

latest coverage across their companies

Pentec Health welcomes Eric C. Mollman as Chief Financial Officer | PR Newswire | wfmz.com

Pentec Health · wfmz.com · Sep 10, 2026

CHG Healthcare Introduces New Program to Help Healthcare Organizations Bridge Urgent and Transitional Workforce Needs

CHG Healthcare · 01net.it · Sep 9, 2026

Beloit community raises millions of dollars for renewed football stadium - Yahoo Sports

Beloit · sports.yahoo.com · Sep 9, 2026

National Hummingbird Day - September 5

Hummingbird · daysofobservance.com · Sep 4, 2026

Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD | Eye Care Network - Ophthalmology Times

Iolyx · ophthalmologytimes.com · Sep 3, 2026

Knipper Health Rebrands as CareTria to Expand Integrated Therapy Initiation Platform | Pharmaceutical Commerce

Knipper · pharmaceuticalcommerce.com · Sep 2, 2026

AllianceBernstein Private Credit Investors | Direct Lending, Fund and Manager Finance, Equity co-investing | AB

PCI · alliancebernstein.com · Sep 1, 2026

Frazier Healthcare completes acquisition of MatrixCare from ResMed By Investing.com

MatrixCare · investing.com · Sep 1, 2026

Fund performance · per public LP disclosures · 7

as of Mar 2025

Fund	Vintage	Committed	Net IRR	TVPI	DPI
Frazier Life Sciences Public Overage FundLPs: Empire State Development – New York Ventures	2022	—	—	1.28x	0.17x
Frazier Life Sciences Public Fund, LPLPs: Empire State Development – New York Ventures	2021	—	—	1.47x	0.37x
Frazier Healthcare Ventures V, L.P.LPs: California State Teachers' Retirement System	2005	—	14.7%	2.28x	2.28x
Frazier Technology Ventures II, L.P.LPs: Public Employee Retirement System of Idaho	2004	—	14.4%	4.46x	4.46x
Frazier Healthcare IV, L.P.LPs: Washington State Investment Board, John D. and Catherine T. MacArthur Foundation	2001	—	0.7%	1.00x	1.04x
Frazier Healthcare III, L.P.LPs: Washington State Investment Board	1998	—	-11.1%	0.50x	0.47x
Frazier Healthcare II, L.P.LPs: Washington State Investment Board	1996	—	6.9%	1.50x	1.46x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Frequently asked questions

How many investments has Frazier Healthcare Partners made?: Frazier Healthcare Partners has 97 tracked investments, 23 of which have exited, including 7 dated in the last 24 months.
What stage does Frazier Healthcare Partners invest at?: Frazier Healthcare Partners invests at the Growth stage.
What is Frazier Healthcare Partners's typical check size?: Frazier Healthcare Partners typically writes checks of $50M – $400M.
What sectors does Frazier Healthcare Partners focus on?: Frazier Healthcare Partners focuses on Biotech, Digital Health, FemTech, Healthtech, Medical Devices, Wellness & Fitness.
Where is Frazier Healthcare Partners located?: Frazier Healthcare Partners is headquartered in Seattle, US.
Who does Frazier Healthcare Partners co-invest with?: Frazier Healthcare Partners most often shares deals with New Enterprise Associates (NEA), Frazier Life Sciences, Kaiser Permanente Ventures, among 68 tracked co-investors.

Media · Podcasts & interviews

featuring the team

13 Brian Morfitt2017 HCFC: Frazier Healthcare Partners | Brian Morfitt

UCI Merage School · Brian Morfitt

Co-investors · 27

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

Both backed · 7

Mirum Pharmaceuticals Bravo Health CHG Healthcare Golden State Medical Supply MBX Biosciences RevSpring U S Renal Care

$200K – $40M

OrbiMed

OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

Both backed · 4

Passage Bio Aspen Neuroscience MBX Biosciences Sidewinder Therapeutics

$1M – $75M

Norwest Venture Partners

Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.

Both backed · 3

Mirum Pharmaceuticals MBX BiosciencesCallio Therapeutics

$10M – $30M

ARCH Venture Partners

ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.

Both backed · 3

Maze Therapeutics Aspen NeuroscienceBE Biopharma

$50K – $250M

Novartis Venture Fund

The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.

Both backed · 3

Alesta Merganser Biotech Sidewinder Therapeutics

$5M – $25M

Nextech Invest

Nextech Invest is a Zurich-based investment firm focused on emerging biotechnology companies, backing transformative cancer medicines and precision medicine advances worldwide.

Both backed · 3

Alpha-9 Oncology Tubulis GmbHBE Biopharma

$648K – $3.2M

Samsara BioCapital

Samsara BioCapital is an investment firm backing the development of transformative therapeutics for patients, bringing together scientists, physicians, drug developers, and business leaders to support next-generation therapeutic breakthroughs.

Both backed · 3

Alpha-9 Oncology HilleVaxBE Biopharma

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

Both backed · 2

Radionetics Oncology Sidewinder Therapeutics

$5M – $25M

5AM Ventures

5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.

Both backed · 2

Inipharm Radionetics Oncology

$100K – $4M

RiverVest Venture Partners

RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.

Both backed · 2

Mirum Pharmaceuticals Bluejay Therapeutics

$500K – $3M

Alta Partners

Alta Partners is a venture capital firm focused on the healthcare and life sciences sector, backing entrepreneurs building companies across biotechnology, therapeutics, and healthcare innovation.

Both backed · 2

Lassen TherapeuticsBE Biopharma

$1M – $12M

General Catalyst

General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.

Both backed · 1

Alpha-9 Oncology

$30M

▶15 more co-investors

Versant Ventures Deerfield Management Company Sanofi Ventures MPM BioImpact Domain Associates Third Rock Ventures Andera Partners Omega Funds New Leaf Venture Partners Westlake Village BioPartners Canaan Partners Venrock Asset Management Ventures Sofinnova Ventures Aisling Capital

Firms observed investing alongside Frazier Healthcare Partners, from public investor directories. Shared companies are the overlap with Frazier Healthcare Partners's recorded portfolio.

Similar investors

WELL Ventures

WELL Health Ventures is the corporate venture arm of WELL Health Technologies, backing digital health companies with an emphasis on modernizing healthcare in Canada.

Portfolia

Portfolia operates venture funds designed by and for women, enabling members to invest collectively in innovative companies while learning together through curated content, founder access, and hands-on deal flow.

$10K

Suncoast Ventures

Suncoast Ventures is a healthcare-focused venture capital firm that backs founders solving present-day healthcare problems, providing relationships, networks, and systems to help companies scale.

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.

$250K

LongeVC

LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.